Bronchiectasis Drugs Market to Witness Astonishing Growth by 2029
Bronchiectasis Drugs Market is anticipated to grow at a significant CAGR during the forecast period. Some pivotal factors that are driving the market growth include the high presence of bronchiectasis among the public and the improved infrastructure facilities in the healthcare and medical sector. Another key factor anticipate to drive the market growth include the constant R&D in the field of bronchiectasis drugs coupled with the rising competition among established drug makers.
Under the global bronchiectasis
drugs market, the major types of drugs available include antibiotics and
expectorants. Among these two, antibiotics have the greater demand and are
anticipated to continue to stay ahead of the expectorant segment in the future
years. An increase in the number of respiratory diseases has been driving the
antibiotics demand. In addition, the low cost and easy availability of these
antibiotics have led to the demand substantially as well.
Some key players operating in the market include
Endo International Plc, GlaxoSmithKline Plc,., Reckitt and Benckiser Group Plc,
among others. These players are eyeing to strengthen their position in the
market by adopting various strategies as mergers and acquisitions,
partnerships, collaborations, new product launch and development in the
existing product portfolio, and so on. For instance, in April 2014, Bayer
HealthCare announced that the US Food and Drug Administration's (FDA) Office of
Orphan Products Development has granted orphan drug designation for its
investigational Ciprofloxacin Dry Powder for Inhalation (Ciprofloxacin DPI) for
the treatment of non-cystic fibrosis bronchiectasis (NCFB). Such approvals for
the novel forms of drugs from the FDA for the treatment of bronchiectasis are
further anticipated to drive the market growth during the forecast period.
To Request
a Sample of our Report on Bronchiectasis Drugs Market: https://www.omrglobal.com/request-sample/bronchiectasis-drugs-market
Market Coverage
·
The market number available for – 2022-2030
·
Base year- 2022
·
Forecast period- 2023-2030
·
Segment Covered
·
Regions Covered- Globally
·
Competitive Landscape: Endo International Plc,
GlaxoSmithKline Plc,., Reckitt and Benckiser Group Plc, among others.
A
full Report of Bronchiectasis Drugs Market is Available at: https://www.omrglobal.com/industry-reports/bronchiectasis-drugs-market
Bronchiectasis Drugs Market by Segmentation
By Product
• Antibiotics
• Expectorants
• Other Drugs
Bronchiectasis Drugs Market by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert research
analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and
consulting company known for its crisp and concise reports. The company is
equipped with an experienced team of analysts and consultants. OMR offers
quality syndicated research reports, customized research reports, consulting
and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and
Consulting Services through another subsidiary Encanto Technologies.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment